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Abstract
Background
This study established evidence about the diagnostic performance of trained giant African
pouched rats for detectingMycobacterium tuberculosis in sputum of well-characterised
patients with presumptive tuberculosis (TB) in a high-burden setting.
Methods
The TB detection rats were evaluated using sputum samples of patients with presumptive
TB enrolled in two prospective cohort studies in Bagamoyo, Tanzania. The patients were
characterised by sputum smear microscopy and culture, including subsequent antigen or
molecular confirmation ofMycobacterium tuberculosis, and by clinical data at enrolment
and for at least 5-months of follow-up to determine the reference standard. Seven trained
giant African pouched rats were used for the detection of TB in the sputum samples after
shipment to the APOPO project in Morogoro, Tanzania.
Results
Of 469 eligible patients, 109 (23.2%) were culture-positive forMycobacterium tuberculosis
and 128 (27.3%) were non-TB controls with sustained recovery after 5 months without anti-
TB treatment. The HIV prevalence was 46%. The area under the receiver operating charac-
teristic curve of the seven rats for the detection of culture-positive pulmonary tuberculosis
was 0.72 (95% CI 0.66–0.78). An optimal threshold could be defined at2 indications by
rats in either sample with a corresponding sensitivity of 56.9% (95% CI 47.0–66.3), specific-
ity of 80.5% (95% CI 72.5–86.9), positive and negative predictive value of 71.3% (95% CI
60.6–80.5) and 68.7% (95% CI 60.6–76.0), and an accuracy for TB diagnosis of 69.6%.
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The diagnostic performance was negatively influenced by low burden of bacilli, and inde-
pendent of the HIV status.
Conclusion
Giant African pouched rats have potential for detection of tuberculosis in sputum samples.
However, the diagnostic performance characteristics of TB detection rats do not currently
meet the requirements for high-priority, rapid sputum-based TB diagnostics as defined by
the World Health Organization.
Introduction
Tuberculosis (TB) is the world’s second deadliest infectious disease, which killed 1.5 million
people in 2013—approximately one person every 25 seconds [1]. A key priority for TB control
is the accurate and early diagnosis in persons with active and potentially infectious TB to
enable timely treatment that both cures patients and decreases transmission risk. The develop-
ment of novel, accurate, robust, and rapid diagnostic capabilities will result in improved case
detection, disease surveillance, healthcare delivery, and quality of future research.
The superior olfactory characteristics of animals have been formerly used for diagnosis of a
variety of diseases. Trained dogs are capable of identifying pulmonary carcinoma in breath
samples [2] or intestinal infections in stool samples [3]. Rats have a highly developed sense of
smell. The number of functional olfactory receptor genes is about 3 times larger in rats than in
humans [4]. Previous investigations suggest that trained giant African pouched rats (Cricet-
omys gambianus) are able to detect and indicate the presence ofMycobacterium tuberculosis
(M.tb) in sputum samples by smelling volatile organic compounds [5][6][7][8][9][10][11]. The
rats presumably detect a combination of volatile organic compounds specific to M. tuberculo-
sis, rather than a single molecule [12]. Consequently, TB detection rats have the potential to
become an alternative or a supplement to sputum smear microscopy which is characterised by
low sensitivity although being the only widely used TB diagnostic in resource-limited settings
[13].
Previous studies on TB detection rats provided proof of concept for the test [5] and showed
its value as a tool for rescreening of samples from microscopy centres (second-line screening)
by increasing TB case detection after microscopy by 31.4%, 44%, and 42.8% in 2008, 2009, and
2010, respectively [6][7][8]. In those studies the TB detection rats’ performance was assessed
against smear microscopy as the reference standard. A recent study has compared the accuracy
of 10 rats in 910 sputum samples with the correspondent outcome from culture on solid media
and subsequent multiplex polymerase chain reaction for species differentiation. The per-
patient analysis showed that the mean sensitivity of the 10 rats used in this experiment was
70.5%, while the mean specificity was 80.5% [10].
However, the diagnostic potential of TB detection rats in respiratory specimen has been so
far only evaluated in sputum previously evaluated in Direct Observation Treatment Short-
Course (DOTS) centres accompanied by no or scarce clinical data, no follow up information,
and without blinding of the involved investigators. For that reason, we have conducted the first
prospective evaluation study on giant African pouched rats to detect TB in adult patients with
symptoms of pulmonary tuberculosis which includes both comprehensive clinical and micro-
biological data. Rigorous evidence-based evaluation of diagnostic tests is essential prior to any
clinical practice to avoid unwanted clinical consequences due to misleading results of test
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accuracy and to limit healthcare costs by preventing unnecessary testing or avoidable follow-
up investigations [14][15].
Methods
Study population
Individuals with signs and symptoms suggestive of pulmonary TB were prospectively recruited
in two cohort studies (TB Cohort and TB CHILD), and followed up for at least 5 months. The
recruitment took place at the Ifakara Health Institute, Bagamoyo, United Republic of Tanzania,
between the 22nd of September 2010 and 8th of March 2012. Bagamoyo, a coastal town of
35,000 inhabitants, is located approximately 70 km north of Tanzania’s largest city Dar es
Salaam. Tanzania is one of the 22 high-burden countries with 295 prevalent bacteriological
confirmed pulmonary TB cases per 100,000 [16] and 37% HIV infection in patients with TB
[1].
Patients were eligible for the study if they presented with persistent cough of two weeks or
more and at least one of the following TB associated findings: haemoptysis, chest pain, fever,
night sweats, constant fatigue, recent unexplained weight loss, loss of appetite, malaise, or con-
tact with a known TB case. Patients who received anti-TB treatment during the past year, were
severely sick from TB or another disease, or did not reside within the study area were excluded
from the study.
A minimum necessary sample size of 403 presumptive TB patients was calculated for the
diagnostic study [17], assuming a prevalence of disease of 20%, an expected sensitivity and
specificity of 70% and 80%, respectively, and a target accuracy of ±5% (i.e. confidence interval
width of 10%) plus a type I error probability of less than 5%.
Classification of patients
The participants were categorised into six groups based on clinical and microbiological assess-
ments, as shown in Table 1. The allocation to the groups was not mutually exclusive, e.g. due to
mixed infection ofM.tb and non-tuberculous mycobacteria (NTM). For the purpose of this
analysis, the classification into group A, B, D, or G supersedes classification to group C.
Study procedures and laboratory methods
Clinical procedures at enrolment comprised medical history, physical examination, voluntary
HIV counselling and testing, and chest radiography. Chest radiographs were interpreted by a
trained radiographer for immediate patient management.
Two sputum samples, one spot and one early morning, were routinely collected and used
for acid-fast bacilli smear, culture examination, and TB detection by giant African pouched
rats. Following NALC-NaOH decontamination, each sputum sample pellet was subjected to
Table 1. Patient classification.
Group Description Short name
A Culture-positive, smear-positive, M. tuberculosis; s+/c+ M.tb
B Culture-positive, smear-negative, M. tuberculosis s-/c+ M.tb
C Culture-positive, non-tuberculous mycobacteria s±/c+ NTM
D Culture-negative pulmonary TB; strong clinical and radiological suspicion s-/c- clin.TB
F Smear-/culture-negative, sustained recovery up to 5th month Controls
G Loss to follow-up after recruitment or any other combination Indeterminate
doi:10.1371/journal.pone.0135877.t001
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microscopy after Ziehl-Neelsen staining. Sputum smear were graded according to the concen-
tration of the bacilli [18]. Each sample was inoculated on both liquid (BACTECMGIT 960,
Becton Dickinson, USA) and solid Löwenstein-Jensen (LJ) culture media. Positive cultures
were confirmed by microscopy for acid fast bacilli and for the presence ofM. tuberculosis by
MPT64 antigen and/or molecular tests (Genotype MTBC, CM, or MTBDRplus, Hain Life-
science, Germany). Genotype CM or AS (Hain Lifescience, Germany) were used for detection
of NTM. GenoType MTBDRplus or phenotypic drug-susceptibility testing (BACTECMGIT
960 SIRE kit, Becton Dickinson, USA) was employed for resistance testing. All tests were per-
formed blinded to clinical or radiological information by qualified laboratory technical person-
nel according to Good Clinical Laboratory Practice. Results from established diagnostic
procedures were made available to support clinical management according to national and
international guidelines.
If the volume of the specimen was appropriate ( 2ml), an aliquot of 1ml was collected
from each unprocessed sputum samples in sterile cryovials before decontamination. The cryo-
vials were stored within 4 hours at minus 20°C. The specimens were transferred under con-
trolled temperature in one shipment to the APOPO laboratory in Morogoro, United Republic
of Tanzania. After thawing, a sterile phosphate buffered saline was added and subsequent heat
inactivation (90°C water bath for 30 min) was performed prior to detection by the giant Afri-
can pouched rats.
TB rats—training and detection sessions
Seven giant African pouched rats were used in succession for the detection of TB in the sputum
samples. The animals had been trained prior to this study using operant conditioning to pause
for at least 5 seconds over TB-positive samples (indicator response) and have passed an inter-
nal accreditation process under blind conditions. Training methods, standardisation of perfor-
mance, quality control and experimental setup have been detailed before [5][7][19].
Prior to the detection sessions, training sessions with 196 sputum samples of known classifi-
cation from the Ifakara Health Institute cohorts were carried out to allow adaptation to poten-
tial influence by factors specific to the site and the materials used (e.g. sputum collection
container).
In the detection sessions, the personnel involved in the experiment at the APOPO labora-
tory were blind to the clinical, radiological, and mycobacteriological information related to the
sputum samples. The samples (one or two per patient) were presented in detection sessions
among samples that were being evaluated for routine second-line screening operations between
10th July and 28th August 2012.
Statistical analysis and reference standard
In the main per-patient analysis, a TB-positive test result was defined as a positive indication
by at least one rat of at least one sample of the patient. In this analysis, diagnostic test perfor-
mance (sensitivity, specificity, predictive values and likelihood ratios) was calculated only in
the groups with defined TB status (reference standard): group A (s+/c+M.tb), group B (s-/c+
M.tb), and group F (controls). The performance has been analysed individually for each of the
rats. Additionally, the performance of all 7 rats combined was analysed using the sum of the
number of rats indicating a TB-positive test result (range 0 to 7) to determine the best thresh-
old; e.g. a patient was considered test-positive if two or more rats indicated either of the sam-
ples of the patient as positive. Moreover, the diagnostic test performance was also assessed in a
per-sample analysis. In this analysis the reference standard was defined as presence or absence
ofM.tb culture-positivity in the corresponding culture sample.
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Receiver operating characteristic (ROC) curves and the areas under the curve (AUC) were
calculated. Proportions were compared using logistic regression models and chi-square test.
The statistical analysis was performed using Stata v13 (Stata Corp., College Station, TX, USA).
The presented diagnostic evaluation study followed guidelines of the TDR Diagnostics Eval-
uation Expert Panel (DEEP) and The Standards for Reporting of Diagnostic Accuracy
(STARD) steering committee for assessing the test performance and operational features of
diagnostics for infectious diseases in the respective target population [20][21].
Ethical considerations
The study protocol and the consent procedure of the TB cohort and TB CHILD study were
approved by the Institutional Review Board of the the Ifakara Health Institute and the Medical
Research Coordinating Committee of Tanzania. Written informed consent was obtained from
a literate patient. In case of illiteracy, informed oral consent was attested by an independent
witness in accordance with Good Clinical Practice (GCP) guidelines [22]. In both cases the
informed consent was documented on a paper-based, dated, signed and/or thumb-printed con-
sent form. The study was conducted in accordance with the Helsinki Declaration [23] and
GCP guidelines [22]. The Medical Research Coordinating Committee of Tanzania has granted
ethics clearance for the use of African giant pouched rats as a potential tool for diagnosis of
tuberculosis. APOPO has an approved Animal Welfare Assurance from the Office of Labora-
tory Animal Welfare (OLAW; Assurance Identification Number A5720-01).
Results
A total of 480 individuals with symptoms suggestive of TB were enrolled; six children and ado-
lescents of less than 15 years of age, one patient who was classified as having exclusively extra-
pulmonary TB and four patients without rat results were excluded from analysis. The 469
eligible study participants were assigned to the classification groups as displayed in Table 2.
About half of the participants were female (49%) and the overall HIV-prevalence was 46%.
The proportion of HIV-infected participants was statistically significant higher in group B (s-/c
+M.tb) compared to all other groups (chi-square 22.21, p<0.001). Details on patient charac-
teristics and symptoms at recruitment are shown in Table 2.
M.tb: per patient analysis
The analysis of the combined diagnostic capability showed that sensitivity decreased with
increasing threshold (indication by1 to 7 rats) and, as an opposing trend, specificity
increased. At the lowest and highest thresholds, sensitivities and specificities amounted to
71.6% (95% CI 62.1–79.8), 59.4 (95% CI 50.3–68.0) and 18.4% (95% CI 11.6–26.9), 97.7%
(95% CI 93.3–99.5), respectively (Table 3).
In the ROC calculation, the optimal diagnostic threshold (minimal square of distance
between the upper left hand corner of ROC and any point on the ROC curve) could be defined
as2 indications by rats. Fig 1 shows the STARD flow diagram for this optimal threshold. The
area under the ROC curve, which determines the inherent validity of the diagnostic approach,
was 0.72 (95 CI% 0.66–0.78) for the detection ofM.tb culture-positive individuals (Fig 2). For
the optimal threshold, this translates to a sensitivity of 56.9% (95% CI 47.0–66.3), specificity of
80.5% (95% CI 72.5–86.9), positive (PPV) and negative predictive value (NPV) of 71.3% (95%
CI 60.6–80.5) and 68.7% (95% CI 60.6–76.0), and an accuracy for TB diagnosis of 69.6%.
The area under the ROC curve differed statistically significant for detection of smear-posi-
tive (p = 0.016),M.tb culture-positive individuals and smear-negative,M.tb culture-positive
individuals (0.78 vs. 0.56; Fig 3). For the optimal threshold, this translates to a sensitivities of
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65.0% (95% CI 53.5–75.3) and 34.5% (95% CI 17.9–54.3) and specificities of 80.5% (95% CI
72.5–86.9) and 80.5% (95% CI 72.5–86.9) for the detection of smear-positive and smear-nega-
tive TB, respectively.
One sputum sample was collected from 122 (26%) patients and two samples were obtained
from 347 (74%) patients. All available samples were tested by TB detection rats. The area
under the ROC curve (graph not shown) did not differ if the rats tested only the first or both
available samples (0.74 vs. 0.76).
There was no statistically significant difference in the performance of TB detection rats com-
paring the area under the ROC curves stratified by HIV status for group A (s+/c+M.tb) and B
(s-/c+M.tb) and group F (control) as reference standards (chi-square 0.3466, p-value = 0.557).
Association analyses were performed under the assumption that2 indications by rats rep-
resent the optimal threshold for TB detection. No statistically significant association was found
between TB detection by rats and age, TB history, or having a cough, hemoptysis, sweating, or
weight loss at recruitment. Having a fever at the time of recruitment was significantly associ-
ated with TB detection by rats (p = 0.003).
Table 2. Patient characteristics and symptoms at recruitment.
Missing
data
All Group A Group B Group C Group D Group F Group G
Culture-
positive,
smear-
positive, M.
tuberculosis
Smear-
negative,
culture-
positive, M.
tuberculosis
Culture-
positive, non-
tuberculous
mycobacteria
Culture-negative
pulmonary TB
(strong clinical
and radiological
suspicion)
Controls, all
smear- /
culture-
negative,
sustained
recovery up to
5th month
Loss to follow-
up after
recruitment or
any other
combination
Characteristics
n (%) 469 80 (17.1) 29 (6.2) 84 (17.8) 9 (1.9) 128 (27.3) 139 (29.4)
Age Mean (SD) 0 41.6
(15.4)
36.8 (12.3) 42.3 (12.7) 43.2 (15.4) 44.9 (10.9) 42.3 (16.3) 42.3 (16.7)
Age Median
(IQR)
0 38
(30–
50)
35 (29–41) 39 (35–43) 42 (30–53.5) 45 (38–51) 39 (29.5–54.5) 39 (30–50)
Female sex—n
(%)
1 231
(49.2)
25 (31.3) 16 (55.2) 51 (60.7) 5 (55.6) 64 (50.0) 70 (50.7)
Body mass index
(kg/m2) Median
(IQR)
2 19.7
(17.7–
22)
18.6 (16.9–20) 18.9 (17.4–
21.8)
19.8 (17.7–22.4) 20.2 (16.1–22.2) 20.6 (18.2–
23.3)
19.4 (17.6–21.7)
HIV positive—n
(%)
31 203
(46.4)
26 (34.7) 24 (82.8) 40 (51.3) 3 (37.5) 48 (40.7) 62 (47.7)
History of TB—n
(%)
1 74
(15.8)
12 (15.0) 2 (6.9) 16 (19.1) 4 (44.4) 13 (10.2) 27 (19.6)
Symptoms at
recruitment
Cough  2
weeks—n (%)
1 442
(94.4)
74 (92.5) 26 (89.7) 80 (95.2) 9 (100) 124 (96.9) 129 (93.5)
Night sweats—n
(%)
1 217
(46.4)
46 (57.5) 12 (41.4) 37 (44.1) 7 (77.8) 48 (37.5) 67 (48.6)
Haemoptysis—n
(%)
9 52
(11.3)
8 (10.0) 1 (3.5) 11 (13.6) 1 (11.1) 14 (11.3) 17 (12.4)
Fever—n (%) 1 241
(51.5)
49 (61.3) 18 (62.1) 44 (52.4) 5 (55.6) 60 (46.9) 65 (47.1)
Weight loss—n
(%)
4 229
(49.3)
50 (62.5) 19 (65.5) 35 (41.7) 3 (33.3) 56 (43.8) 66 (48.9)
doi:10.1371/journal.pone.0135877.t002
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The diagnostic performance differed considerably between the individual rats, e.g. a statisti-
cally significant higher sensitivity was achieved by rat no.6 (57.8%; 95% CI 48.0%-67.2%) com-
pared to rats no.2 and no.7 (31.2%; 95% CI 22.7%-40.8%). The specificity for six of the seven
rats was above 80% (Table 3).
M.tb: per sample analysis
In a per-sample analysis (n = 819), using presence or absence ofM.tb growth in the culture of
the same sample as reference standard, the indicators of test performance, in particular the sen-
sitivity, were overall poor. Depending on the threshold, the sensitivity ranged from 45.8% (95%
CI 40.3–51.4) to 5.9% (95% CI 3.6–9.0) and specificity from 73.8 (95% CI 69.7–77.7) to 99.0
(95% CI 97.6–99.7). The area under the ROC curve for the per-sample analysis was 0.61.
A per-sample sub-analysis in group A (s+/c+M.tb; n = 134) showed a statistically significant
association between grading of sputum smear and TB detection by rats with higher AFB results
having more TB detection (chi-square 17.31, p = 0.002).
Table 3. Diagnostic test performance of TB detection rats (per-patient analysis; all samples).
Culture-positive TB
cases (Group A&B)
versus Controls (Group
F)
Threshold
(Number of rats
indicating TB)
Sensitivity Specificity Positive
Predictive
Value
Negative
Predictive
Value
Positive
Likelihood
Ratio
Negative
Likelihood
Ratio
N = 237 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Rat 1 42.2 (32.8–
52.0)
89.8 (83.3–
94.5)
78.0 (65.3–
87.7)
64.6 (57.1–
71.6)
4.16 (2.37–
7.28)
0.64 (0.54–
0.76)
Rat 2 31.2 (22.7–
40.8)
93.0 (87.1–
96.7)
79.1 (64.0–
90.0)
61.3 (54.1–
68.2)
4.44 (2.23–
8.83)
0.74 (0.65–
0.85)
Rat 3 42.2 (32.8–
52.0)
83.6 (76.0–
89.5)
68.7 (56.2–
79.4)
62.9 (55.2–
70.2)
2.57 (1.64–
4.03)
0.69 (0.58–
0.83)
Rat 4 42.2 (32.8–
52.0)
87.5 (80.5–
92.7)
74.2 (61.5–
84.5)
64.0 (56.4–
71.1)
3.38 (2.03–
5.61)
0.66 (0.56–
0.79)
Rat 5 39.4 (30.2–
49.3)
85.9 (78.7–
91.4)
70.5 (57.4–
81.5)
62.5 (54.9–
69.7)
2.81 (1.72–
4.57)
0.70 (0.60–
0.83)
Rat 6 57.8 (48.0–
67.2)
78.9 (70.8–
85.6)
70.0 (59.4–
79.2)
68.7 (60.5–
76.1)
2.74 (1.89–
3.97)
0.53 (0.42–
0.68)
Rat 7 31.2 (22.7–
40.8)
89.8 (83.3–
94.5)
72.3 (57.4–
84.4)
60.5 (53.2–
67.5)
3.07 (1.71–
5.52)
0.77 (0.67–
0.88)
Mean 40.9 (37.5–
44.3)
86.9 (85.2–
88.7)
73.3 (71.7–
74.8)
63.5 (62.0–
64.5)
3.31 (3.03–
3.59)
0.68 (0.65–
0.71)
1 71.6 (62.1–
79.8)
59.4 (50.3–
68.0)
60.0 (51.0–
68.5)
71.0 (61.5–
79.4)
1.76 (1.38–
2.24)
0.48 (0.34–
0.67)
2 56.9 (47.0–
66.3)
80.5 (72.5–
86.9)
71.3 (60.6–
80.5)
68.7 (60.6–
76.0)
2.91 (1.98–
4.29)
0.54 (0.42–
0.68)
3 47.7 (38.1–
57.5)
88.3 (81.4–
93.3)
77.6 (65.8–
86.9)
66.5 (58.8–
73.5)
4.07 (2.43–
6.81)
0.59 (0.49–
0.72)
All rats combined 4 36.7 (27.7–
46.5)
92.2 (86.1–
96.2)
80.0 (66.3–
90.0)
63.1 (55.8–
70.0)
4.70 (2.47–
8.95)
0.69 (0.59–
0.80)
5 29.4 (21.0–
38.8)
95.3 (90.1–
98.3)
84.2 (68.7–
94.0)
61.3 (54.2–
68.1)
6.26 (2.72–
14.42)
0.74 (0.65–
0.84)
6 25.7(17.8–
34.9)
95.3 (90.1–
98.3)
82.4 (65.5–
93.2)
60.1 (53.0–
66.9)
5.48 (2.36–
12.74)
0.78 (0.69–
0.88)
7 18.4 (11.6–
26.9)
97.7 (93.3–
99.5)
87.0 (66.4–
97.2)
58.4 (51.5–
65.1)
7.83 (2.39–
25.64)
0.84 (0.76–
0.92)
CI = Confidence interval.
doi:10.1371/journal.pone.0135877.t003
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Fig 1. STARD flow chart for diagnostic threshold of2 indications by rats.
doi:10.1371/journal.pone.0135877.g001
Fig 2. ROC analysis for the detection ofM.tb culture-positive individuals for different indication
thresholds (per-patient analysis; all samples). (Standard error 0.03, 95 CI% 0.66–0.78).
doi:10.1371/journal.pone.0135877.g002
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NTM: sub-analysis
Group C (s ±/c+ NTM) encompassed patients with exclusively NTM in the sputum sample
irrespective of a potential clinical relevance. In this group, 21 of 84 patients (25%) had a posi-
tive rat result (at least one sample with2 indications). The per-sample analysis exhibited that
19.6% of the samples with concurrent identification of one or more NTM were rat-positive
using the threshold of2 indications. The proportion of rat-positive samples in the samples
with the identified NTMs is displayed in Table 4.
Fig 3. ROC analysis for the detection of smear-positive (A) versus smear negative (B)M.tb culture-
positive individuals for indication thresholds (per-patient analysis; all samples). (A: Standard error
0.03, 95 CI% 0.71–0.84; B: Standard error 0.06, 95 CI% 0.45–0.67).
doi:10.1371/journal.pone.0135877.g003
Table 4. Rat-positive samples (two or more indications) in group C (s ±/c+ NTM) with concurrent
molecular test result (per-sample analysis).
Molecular differentiation of non-tuberculous mycobacteria 2 rat indications
M. abscessus/M. immunogenum 0/1
M. asiaticum 3/10
M. avium 0/2
M. celatum 0/2
M. fortuitum 1 2/13
M. fortuitum 2/M. mageritense 1/12
M. godii 0/1
M. gordonae 1/2
M. intracellulare 4/15
M. malmoense 0/1
M. malmoense/M.haemophilum/M. patustre 0/2
M. scrofulaceum 1/7
M. scrofulaceum and M.celatum 0/1
M. simiae 2/5
M. smegmatis 0/2
M. szulgai/M.intermedium 1/1
High GC Gram positive bacterium 2/7
Mycobacterium species* 1/16
*Species could not be determined by Hain GenoType Mycobacterium CM/AS
doi:10.1371/journal.pone.0135877.t004
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Discussion
Giant African pouched rats can detect M. tuberculosis in clinical sputum samples with a fair
sensitivity (56.9%) and moderate specificity (80.5%) compared to culture as reference standard
if an indicator response from two or more out of seven rats is treated as a positive diagnostic
indicator.
This is the first evaluation of the diagnostic performance of TB detection rats which includes
microbiological investigations with liquid and solid culture, subsequent differentiation of spe-
cies, combined with a comprehensive clinical data set from each patient. Solid culture (LJ) has
been used as reference standard in previous studies on TB detection rats either without [5] or
with identification by subsequent multiplex real-time PCR [10][24]. However, detailed clinical
data were not available in any of those studies. Dissimilarities in study design impede the direct
comparison between the presented and former studies. In one study with culture and multiplex
PCR using 10 instead of 7 rats [10], the per-patient sensitivity was higher (81.9% vs. 56.9%)
and the specificity was lower (64.5% vs. 80.5%) at a diagnostic threshold of2 indications. The
difference in diagnostic accuracy at the defined threshold is most probably influenced by the
different total number of rats used, resulting in a trade-off in sensitivity and a gain of specificity
at the threshold of2 in the presented compared to the previous study.
The presented data suggest that the performance of the TB detection rats depends on the
bacterial load in sputum samples. TB was detected with a higher sensitivity in smear positive
compared to smear negative, culture-positive TB patients. Moreover, the detection was signifi-
cantly better in sputum samples with higher microscopy grade, a surrogate for high concentra-
tion of bacilli.
In general, the diagnostic performance was equally good if only one or two samples were
used for detection.
Interestingly, the sensitivity and specificity for detecting TB did not differ significantly
between HIV-infected and HIV-uninfected patients, although in general sputa of HIV-infected
patients have a lower burden of TB bacilli [25][26]. Further HIV-related differences in symbi-
otic or pathogenic respiratory and oral microorganisms [27][28][29] with different bouquets of
volatiles, seem to have no impact on diagnostic performance of the giant African pouched rats.
The seven rats did not perform with the same diagnostic accuracy: specificity and particu-
larly sensitivity varied considerably between the individual rats. The findings contrast those of
preceding studies [5][6] which report consistent performance characteristics for each rat. Ten-
tatively, different levels of operant conditioning training, but also other influences, e.g. related
to the patient group, might be accountable for the observed variability.
In previous studies, the rats detected TB in the same sputum containers which were earlier
also used for collection at the microscopy centres. Yet, in the presented study the specimens
have been transferred to cryovials before frozen, thawed and subsequently evaluated by the
rats. It remains speculative, if the background odour of the container used for sputum collec-
tion has any potential effect on the diagnostic performance of the rats. According to unpub-
lished data, the intermediate freezing of specimens does not seem to have an influence on the
diagnostic performance of the TB detection rats [10].
The odour ofM.tb does not consist of a single compound but rather a combination of vola-
tiles which is characteristic forMt.b (‘smellprint’) and does, with regard to many volatiles, not
overlap with compounds of non-tuberculous mycobacteria or other pathogenic and apatho-
genic microorganisms of the respiratory tract [11][30][31]. In approximately 80% of the sam-
ples with NTM only, the rats did not indicate for TB in the presented clinical evaluation. The
findings suggest that trained giant African pouched rats can discriminateM.tb-specific volatile
compounds from non-tuberculous odours to a certain degree. This has been also similarly
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demonstrated in comprehensive experiments on cultured microbes and clinical sputa from
microscopy centres [9][24].
Since one rat can screen 140 sputum samples in 40 minutes [5], large-volume second-line
screening of sputum samples from microscopy centres in combination with a confirmatory test
with high specificity could be a potential cost-effective application of detection rats technology.
The high sample throughput and low cost make TB detection rats also a possible technology
for active TB case finding in populations at high risk for TB, such as prison populations. How-
ever, the sensitivity would need to be further optimised, before TB detection rats can be used
systematically for TB screening [32].
A limitation of the study is that the giant African pouched rats were primarily trained to
perform an operant discrimination on high-intensity stimuli (high concentration of bacilli).
This could explain the tendency towards superior detection in this kind of specimen. At the
time of this publication, rats are now primarily trained sputum samples with low concentration
of bacilli to improve performance with low concentration samples.
The objectives of this study were limited to the assessment of test accuracy in adult individu-
als with presumptive TB. Operational issues regarding a routine implementation of the tech-
nology on microscopy level and a potential scale up to different settings or countries with high
burden of TB have not been addressed. In future, these research questions will become increas-
ingly relevant, because until now breeding, training and diagnostic performance of TB detec-
tion rats has been only managed by APOPO, a non-governmental organisation using rats for
TB detection in Tanzania and Mozambique.
In summary, giant African pouched rats have the potential for detection of tuberculosis in
sputum samples. However, the diagnostic performance characteristics in this clinical evalua-
tion were less favourable than those reported in previous diagnostic studies in less- or non-
characterised patients [5][8][10][24].
Based on current evidence, rat technology as a standalone diagnostic test, does not fulfil the
criteria for a rapid sputum-based test for detecting TB at the microscopy-centre level of the
health-care system as it has been defined by the World Health Organization in 2014 at a stake-
holder meeting on high-priority target product profiles [33][34].
Future efforts in research and development should be used to further improve the rat tech-
nology, to explore prospects for implementation and scale up and to determine its potential
position in TB diagnostic or screening algorithms.
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